PKM and pancreatic neoplasm: Switching PKM splicing to favor PKM1 variant in drug resistant pancreatic cancer cells rescues sensitivity to gemcitabine and cisplatin, suggesting that PKM2 expression is required to withstand drug-induced genotoxic stress [175].